Analysis of the interaction between the HIV-Inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

被引:67
作者
O'Keefe, BR
Shenoy, SR
Xie, D
Zhang, WT
Muschik, JM
Currens, MJ
Chaiken, I
Boyd, MR
机构
[1] Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag, Dev Therapeut Program, Lab Drug Discovery Res & Dev,SAIC Frederick, Frederick, MD 21702 USA
[2] Frederick Canc Res & Dev Ctr, SAIC Frederick, Struct Biochem Program, Frederick, MD 21702 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1124/mol.58.5.982
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The novel virucidal protein cyanovirin-N (CV-N) binds with equally high affinity to soluble forms of either H9 cell-produced or recombinant glycosylated HIV-1 gp120 (sgp120) or gp160 (sgp160). Fluorescence polarization studies showed that CV-N is also capable of binding to the glycosylated ectodomain of the HIV-envelope protein gp41 (sgp41) (as well as SIV glycoprotein 32), albeit with considerably lower affinity than the sgp120/CV-N interaction. Pretreatment of CV-N with either sgp120 or sgp41 abrogated the neutralizing activity of CV-N against intact, infectious HIV-1 virions. Isothermal calorimetry and optical biosensor binding studies showed that CV-N bound to recombinant sgp120 with a K-d value ranging from 2 to 45 nM and to sgp41 with a K-d value of 606 nM; furthermore, they indicated an approximate 5:1 stoichiometry for CV-N binding to sgp120 and a 1:1 stoichiometry for CV-N binding to sgp41. Circular dichroism studies additionally illuminated the binding of CV-N with both sgp120 and sgp41, providing the first direct evidence that conformational changes are a consequence of CV-N interactions with both HIV-1 envelope glycoproteins.
引用
收藏
页码:982 / 992
页数:11
相关论文
共 33 条
[1]   EVALUATION OF SECONDARY STRUCTURE OF PROTEINS FROM UV CIRCULAR-DICHROISM SPECTRA USING AN UNSUPERVISED LEARNING NEURAL-NETWORK [J].
ANDRADE, MA ;
CHACON, P ;
MERELO, JJ ;
MORAN, F .
PROTEIN ENGINEERING, 1993, 6 (04) :383-390
[2]   Solution structure of cyanovirin-N, a potent HIV-inactivating protein [J].
Bewley, CA ;
Gustafson, KR ;
Boyd, MR ;
Covell, DG ;
Bax, A ;
Clore, GM ;
Gronenborn, AM .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (07) :571-578
[3]   Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530
[4]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[5]   Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses [J].
Dey, B ;
Lerner, DL ;
Lusso, P ;
Boyd, MR ;
Elder, JH ;
Berger, EA .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4562-4569
[6]   On the meaning of affinity: Cluster glycoside effects and concanavalin A [J].
Dimick, SM ;
Powell, SC ;
McMahon, SA ;
Moothoo, DN ;
Naismith, JH ;
Toone, EJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (44) :10286-10296
[7]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[8]   Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120 [J].
Esser, MT ;
Mori, T ;
Mondor, I ;
Sattentau, QJ ;
Dey, B ;
Berger, EA ;
Boyd, MR ;
Lifson, JD .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4360-4371
[9]   THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION [J].
FREED, EO ;
MARTIN, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :23883-23886
[10]  
GEYER H, 1988, J BIOL CHEM, V263, P11760